![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1625185
ÀÚµ¿ ºÀÇÕ ±â±â ½ÃÀå ¿¹Ãø(-2030³â) : Á¦Ç° À¯Çü, ±â¼ú, À¯Åë ä³Î, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº° ¼¼°è ºÐ¼®Automated Suturing Devices Market Forecasts to 2030 - Global Analysis By Product Type, Technology, Distribution Channel, Application, End User and By Geography |
Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ ÀÚµ¿ ºÀÇÕ ±â±â ½ÃÀåÀº 2024³â¿¡ 35¾ï ´Þ·¯¸¦ Â÷ÁöÇÏ¸ç ¿¹Ãø ±â°£ Áß CAGR 9.4%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 60¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.
ÀÚµ¿ ºÀÇÕ±â´Â ´Ù¾çÇÑ ÀÇ·á ÀýÂ÷¿¡¼ ºÀÇÕ °úÁ¤À» ÀÚµ¿ÈÇϱâ À§ÇØ ¼³°èµÈ ÷´Ü ¼ö¼ú ÀåºñÀÔ´Ï´Ù. ÀÌ Àåºñ´Â Á¶Á÷ÀÇ Á¤È®ÇÑ ºÀÇÕÀ» °¡´ÉÇϰÔÇÏ´Â ¸ÞÄ¿´ÏÁòÀ» °®Ãß°íÀÖ¾î ÀÎÀ§ÀûÀÎ ½Ç¼ö¸¦ ÁÙÀÌ°í ¼ö¼ú È¿À²¼ºÀ» ³ôÀÔ´Ï´Ù. ÀÚµ¿ ºÀÇÕ±â´Â ÀÏȸ¿ë°ú Àç»ç¿ëÀÌ °¡´ÉÇϸç, ÀÏ¹Ý ¿Ü°ú¼ö¼úºÎÅÍ ½ÉÀå ¹× ÈäºÎ ¼ö¼ú, ¼Òȱ⠼ö¼ú°ú °°Àº Ư¼ö ºÐ¾ß¿¡ À̸£±â±îÁö ´Ù¾çÇÑ ¿ëµµ·Î »ç¿ëµË´Ï´Ù.
WHOÀÇ Ã߻꿡 µû¸£¸é ±³Åë»ç°í·Î ÀÎÇÑ »ç¸ÁÀÚ´Â Àü ¼¼°è¿¡¼ ¾à 119¸¸ ¸í, Ä¡¸íÀûÀÌÁö ¾ÊÀº ºÎ»óÀÚ´Â 2,000¸¸ ¸í¿¡¼ 5,000¸¸ ¸í¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.
ÃÖ¼Òħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
ÃÖ¼Òħ½À¼ö¼ú(MIS)¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼ ÀÚµ¿ºÀÇձ⠽ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ȯÀÚ¿Í ÀÇ·áÁøÀÌ ´õ ÀÛÀº Àý°³, ´õ ÀûÀº ÈäÅÍ, ´õ ºü¸¥ ȸº¹ ½Ã°£, ´õ ³·Àº °¨¿° À§ÇèÀ¸·Î ÀÎÇØ MIS°¡ ³Î¸® º¸±ÞµÇ°í ÀÖ½À´Ï´Ù. ÀÚµ¿ ºÀÇÕ±â´Â ÀÌ·¯ÇÑ ÀýÂ÷¿¡¼ Áß¿äÇÑ ¿ªÇÒÀ» ¼öÇàÇÏ¿© Á¤È®µµ¸¦ ³ôÀ̰í ÀÎÀû ¿À·ù¸¦ ÁÙÀÌ¸ç ºÀÇÕ °úÁ¤À» °£¼ÒÈÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Àåºñ´Â È¿À²¼ºÀ» °³¼±ÇÏ°í »óó ºÀÇÕÀ» ºü¸£°Ô ÇÔÀ¸·Î½á MISÀÇ ¼º°ø¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. Àü ¼¼°è¿¡¼ ÃÖ¼Òħ½ÀÀû ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áö¼ÓÀûÀ¸·Î Áõ°¡ÇÔ¿¡ µû¶ó ÀÚµ¿ ºÀÇÕ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
±³À°°ú ±â¼úÀÇ Çʿ伺
ÀÚµ¿ ºÀÇձ⠽ÃÀå¿¡¼ Àü¹®Àû ÈÆ·Ã°ú ±â¼úÀÇ Çʿ伺Àº Å« µµÀüÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àåºñ´Â Á¤È®¼º°ú È¿À²¼ºÀ» Çâ»ó½ÃŰÁö¸¸ È¿°úÀûÀ¸·Î ÀÛµ¿ÇÏ·Á¸é ÀÇ·á Àü¹®°¡, ƯÈ÷ ¿Ü°ú Àǻ簡 Àü¹®ÀûÀÎ ±³À°À» ¹Þ¾Æ¾ß ÇÕ´Ï´Ù. ÈÆ·ÃÀÌ ÃæºÐÇÏÁö ¾ÊÀ¸¸é ½Ã¼ú Áß ÃÖÀûÀÇ ¼º´ÉÀ» ¾òÁö ¸øÇϰųª ¿À·ù°¡ ¹ß»ýÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ º´¿ø°ú ¼ö¼ú¼¾ÅÍ´Â Á÷¿ø ±³À°¿¡ ½Ã°£°ú ÀÚ¿øÀ» ÅõÀÚÇØ¾ß Çϸç, ÀÌ·Î ÀÎÇØ ½Å±â¼ú µµÀÔÀÌ Áö¿¬µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼÷·Ãµµ ¿ä±¸ »çÇ×Àº ƯÈ÷ ÀÚ¿øÀÌ ºÎÁ·ÇÑ Áö¿ª¿¡¼ ÀÚµ¿ ºÀÇÕ ±â¼úÀÇ º¸±ÞÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.
½ÅÈï ½ÃÀåÀÇ ÇコÄɾî ÀÎÇÁ¶ó ¼ºÀå
ÀÚµ¿ ºÀÇձ⠼ö¿ä´Â ½ÅÈï ½ÃÀåÀÇ ÀÇ·á ÀÎÇÁ¶ó È®ÀåÀÌ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. Áßµ¿, ¾Æ½Ã¾ÆÅÂÆò¾ç ¹× ¶óƾ¾Æ¸Þ¸®Ä« ±¹°¡µéÀÌ ÀÇ·á ½Ã½ºÅÛ Çö´ëÈ ¹× È®ÀåÀ» À§ÇØ ÅõÀÚÇÔ¿¡ µû¶ó ÷´Ü ÀÇ·á ±â¼úÀÌ Á¡Á¡ ´õ ¸¹ÀÌ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á ±â°üÀÌ ¾÷¹« È¿À²¼ºÀ» ³ôÀ̰í, ȸº¹ ½Ã°£À» ´ÜÃàÇϰí, ¼ö¼ú °á°ú¸¦ °³¼±Çϱâ À§ÇØ ³ë·ÂÇÏ¸é¼ ÀÚµ¿ ºÀÇÕ±âÀÇ º¸±ÞÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¼ö¼ú °Ç¼ö Áõ°¡¿Í ÃÖ¼Òħ½ÀÀû ±â¼ú¿¡ ´ëÇÑ Áö½Ä Áõ°¡´Â ÀÌ·¯ÇÑ ÀåºñÀÇ Ã¤ÅÃÀ» ´õ¿í °¡¼ÓÈÇÏ°í ½ÅÈï ±¹°¡¿¡¼ ½ÃÀå È®´ë¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
³ôÀº Ãʱ⠺ñ¿ë
ÀÚµ¿ºÀÇÕ±âÀÇ ³ôÀº Ãʱ⠺ñ¿ëÀº ƯÈ÷ ÀÚ¿øÀÌ ºÎÁ·ÇÑ È¯°æ¿¡¼´Â º¸±Þ¿¡ Å« °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ³ôÀº Ãʱ⠺ñ¿ëÀ¸·Î ÀÎÇØ ÷´Ü Àåºñ, ƯÈ÷ ·Îº¿ º¸Á¶ ºÀÇÕ ½Ã½ºÅÛÀº °³¹ßµµ»ó±¹ÀÇ ¼Ò±Ô¸ð Ŭ¸®´Ð, º´¿ø ¹× ÀÇ·á ½Ã¼³¿¡¼ Á¢±ÙÇÏ±â ¾î·Æ½À´Ï´Ù. À¯Áöº¸¼ö, ±³À° ¹× ¸ê±ÕÀÌ ÇÊ¿äÇϹǷΠÀüü ºñ¿ëÀÌ Áõ°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº Á¤È®¼º°ú È¿À²¼º Ãø¸é¿¡¼ Àå±âÀûÀÎ ÀÌÁ¡ÀÌ ÀÖÁö¸¸, Ãʱ⠺ñ¿ëÀÌ ³ô±â ¶§¹®¿¡ ÀÇ·áÁøÀÌ ¼ö¼ú ÀýÂ÷¿¡ µµÀÔÇÏ´Â °ÍÀ» ÁÖÀúÇÒ ¼ö ÀÖÀ¸¸ç, À̴ ƯÁ¤ ½ÃÀå¿¡¼ ½ÃÀå È®´ë¿¡ Àå¾Ö°¡ µÉ ¼ö ÀÖ½À´Ï´Ù.
COVID-19ÀÇ ¿µÇâ
COVID-19 ÆÒµ¥¹ÍÀº ÀÚµ¿ ºÀÇձ⠽ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. Ãʱ⿡´Â COVID-19 ȯÀÚ Ä¡·á¸¦ ¿ì¼±½ÃÇϱâ À§ÇØ ¼±ÅÃÀû ¼ö¼úÀÌ ¿¬±âµÇ¸é¼ ÀÌ·¯ÇÑ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ °¨¼ÒÇß½À´Ï´Ù. ±×·¯³ª ÆÒµ¥¹ÍÀÌ ÁøÇàµÊ¿¡ µû¶ó COVID-19 ÇÕº´Áõ°ú °ü·ÃµÈ ¼ö¼ú °Ç¼ö Áõ°¡¿Í °¨¿° À§ÇèÀ» ÁÙÀ̱â À§ÇÑ ÃÖ¼Òħ½À ¼ö¼úÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ·¯ÇÑ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çß½À´Ï´Ù. ¶ÇÇÑ ÆÒµ¥¹ÍÀº È¿À²¼ºÀ» ³ôÀÌ°í ¹ÙÀÌ·¯½º¿¡ ³ëÃâµÉ À§ÇèÀ» ÁÙÀ̱â À§ÇØ ÀÚµ¿ ºÀÇձ⸦ Æ÷ÇÔÇÑ Ã·´Ü ±â¼úÀÇ Ã¤ÅÃÀ» °¡¼ÓÈÇß½À´Ï´Ù.
¿¹Ãø ±â°£ Áß ÀϹݿܰú ºÐ¾ß°¡ °¡Àå Å« ½ÃÀåÀ¸·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀÏ¹Ý ¼ö¼ú ºÐ¾ß´Â Á¤È®µµ Çâ»ó, ¼ö¼ú ½Ã°£ ´ÜÃà ¹× È¯ÀÚ °á°ú °³¼±ÀÇ Çʿ伺À¸·Î ÀÎÇØ °¡Àå Å« ±Ô¸ð¸¦ Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ Àåºñ´Â ´õ ºü¸£°í ÀϰüµÈ ºÀÇÕÀ» Á¦°øÇϸç, ÀÌ´Â Å»Àå º¹¿ø, ¸ÍÀå ¹× ´ã³¶ ¼ö¼ú°ú °°Àº ÀÏ»óÀûÀÎ ¼ö¼ú¿¡¼ ƯÈ÷ °¡Ä¡°¡ ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¤È®ÇÑ Á¶Á÷ Æó¼â°¡ ÇÊ¿äÇÑ ÃÖ¼Òħ½À ¼ö¼ú¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼ ÀÚµ¿ºÀÇÕ±â äÅÃÀÌ È®´ëµÇ°í ÀÖÀ¸¸ç, ÀÌ´Â ¼ö¼ú È¿À²À» ³ôÀ̰í ÇÕº´Áõ ¹ß»ý·üÀ» ³·Ãß´Â µ¥ µµ¿òÀÌ µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
¿¬±¸±â°ü ºÎ¹®Àº ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¿¬±¸±â°ü ºÎ¹®Àº ¼ö¼ú ±â¼ú°ú ±â¹ýÀ» ¹ßÀü½ÃŰ´Â ¿ªÇÒÀ» ´ã´çÇϰí ÀÖÀ¸¸ç, ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌµé ¿¬±¸ ±â°üÀº ƯÈ÷ º¹ÀâÇÑ ¼ö¼úÀ̳ª Ư¼ö ¼ö¼ú¿¡¼ ÀÚµ¿ ºÀÇÕ±âÀÇ »õ·Î¿î ¿ëµµ¸¦ °³Ã´ÇÏ´Â µ¥ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·á±â±â Á¦Á¶¾÷ü¿ÍÀÇ °øµ¿ ¿¬±¸¸¦ ÅëÇØ ÀÓ»ó ¿¬±¸¸¦ ÃËÁøÇÏ¿© ÀÚµ¿ ºÀÇձⰡ ÁøÈÇÏ´Â ¿Ü°ú¼ö¼úÀÇ ¿ä±¸¸¦ ÃæÁ·½Ã۰í ȯÀÚ °á°ú¸¦ °³¼±ÇÏ´Â µ¥ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÇ·á ÀÎÇÁ¶óÀÇ ±Þ¼ÓÇÑ ¹ßÀü, ¼ö¼ú °Ç¼ö Áõ°¡, ÃÖ¼Òħ½À¼ö¼ú(MIS) äÅà Áõ°¡·Î ÀÎÇØ ¿¹Ãø ±â°£ Áß °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Áß±¹, Àεµ, ÀϺ»°ú °°Àº ±¹°¡µéÀÌ ÀÇ·á ½Ã½ºÅÛ Çö´ëÈ¿¡ ÅõÀÚÇÔ¿¡ µû¶ó ÷´Ü ¼ö¼ú ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÌ Áö¿ªÀÇ Àα¸ Áõ°¡¿Í °í·ÉÈ´Â ÀÇ·á Çõ½Å¿¡ ´ëÇÑ Á¢±Ù¼º Çâ»ó°ú ÇÔ²² ÀÚµ¿ ºÀÇÕ±â¿Í °°Àº Á¤È®Çϰí È¿À²ÀûÀÎ ¼ö¼ú ±â±â¿¡ ´ëÇÑ Çʿ伺À» ÃËÁøÇÏ¿© ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
¿¹Ãø ±â°£ Áß ºÏ¹Ì°¡ °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À̴ ÷´Ü ÀÇ·á ÀÎÇÁ¶ó, ÃÖ¼Òħ½À¼ö¼ú(MIS)ÀÇ ³ôÀº äÅ÷ü, Á¤¹Ð ¼ö¼ú¿¡ ´ëÇÑ °ü½É Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ÀÌ Áö¿ªÀÇ °í·ÉÈ¿Í ¼ö¼ú Áõ°¡·Î ÀÎÇØ È¿À²ÀûÀÌ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â ºÀÇÕ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ´õ¿í Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ÀÇ·á±â±â Á¦Á¶¾÷üÀÇ Á¸Àç°¨, ·Îº¿ º¸Á¶ ¼ö¼úÀÇ ±â¼ú Çõ½Å, ÀÇ·áºñ ÁöÃâ Áõ°¡ µîÀÌ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖÀ¸¸ç, ºÏ¹Ì´Â ÀÚµ¿ ºÀÇÕ±âÀÇ ÁÖ¿ä ½ÃÀåÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù.
According to Stratistics MRC, the Global Automated Suturing Devices Market is accounted for $3.50 billion in 2024 and is expected to reach $6.00 billion by 2030 growing at a CAGR of 9.4% during the forecast period. Automated suturing devices are advanced surgical tools designed to automate the suturing process during various medical procedures. These devices are equipped with mechanisms that enable precise stitching of tissues, reducing human error and enhancing surgical efficiency. Automated suturing devices can be disposable or reusable, and are employed in applications ranging from general surgery to specialized fields like cardiothoracic and gastrointestinal surgery.
According to WHO estimates approximately 1.19 million people die due to road traffic crashes, and between 20 and 50 million more suffer non-fatal injuries globally.
Growing demand for minimally invasive surgeries
The increasing preference for minimally invasive surgeries (MIS) is a key factor driving the growth of the automated suturing devices market. As patients and healthcare providers seek procedures that offer smaller incisions, reduced scarring, quicker recovery times, and lower risk of infection, MIS has gained widespread popularity. Automated suturing devices play a critical role in these procedures, enhancing precision, reducing human error, and streamlining the suturing process. By improving efficiency and enabling faster wound closure, these devices contribute to the success of MIS. As the global trend toward minimally invasive procedures continues to grow, it is expected that demand for automatic suturing solutions will increase.
Training and skill requirements
The need for specialized training and skills poses a considerable challenge in the automated suturing devices market. While these devices offer enhanced precision and efficiency, they require healthcare professionals, particularly surgeons, to undergo specialized training to operate them effectively. Inadequate training may lead to suboptimal performance or errors during procedures. Furthermore, hospitals and surgical centers must invest time and resources in training staff, which can delay the adoption of new technologies. This requirement for skilled personnel may hinder the widespread use of automated suturing technology, particularly in areas with low resources.
Healthcare infrastructure growth in emerging markets
The need for automated suturing devices is being driven by the expansion of healthcare infrastructure in emerging markets. Advanced medical technology are becoming more and more necessary as nations in the Middle East, Asia-Pacific, and Latin America make investments to modernize and expand their healthcare systems. As medical facilities strive to increase operational efficiency, decrease recuperation times, and improve surgical results, automated suturing devices are becoming more and more popular. Further accelerating up the adoption of these devices and promoting market expansion in emerging nations are the increasing number of surgical procedures and increased knowledge of minimally invasive techniques.
High initial cost
The substantial upfront cost of automated suturing devices poses a major obstacle to their widespread adoption, particularly in resource-limited environments. Due to their high upfront costs, advanced devices especially robotic-assisted suturing systems are less affordable for smaller clinics, hospitals, and healthcare facilities in developing nations. The overall cost may be increased by the high cost of maintenance, training, and sterilization requirements. Although these technologies have long-term advantages in terms of accuracy and efficiency, the initial cost might deter medical professionals from incorporating them into their surgical procedures, which might hinder market expansion in certain markets.
Covid-19 Impact
The COVID-19 pandemic significantly impacted the automated suturing devices market. Initially, the demand for these devices decreased due to the postponement of elective surgeries to prioritize COVID-19 patient care. However, as the pandemic progressed, the demand for these devices increased due to the rising number of surgeries related to COVID-19 complications and the increasing adoption of minimally invasive surgeries to reduce the risk of infection. Additionally, the pandemic accelerated the adoption of advanced technologies, including automated suturing devices, to improve efficiency and reduce the risk of exposure to the virus.
The general surgery segment is expected to be the largest during the forecast period
The general surgery segment is estimated to be the largest, due to the need for enhanced precision, reduced surgical time, and improved patient outcomes. These devices offer faster and more consistent suturing, which is especially valuable in routine procedures such as hernia repairs, appendectomies, and gallbladder surgeries. Additionally, the increasing focus on minimally invasive techniques, which require precise tissue closure, has led to greater adoption of automated suturing devices, improving surgical efficiency and reducing complication rates.
The research institutions segment is expected to have the highest CAGR during the forecast period
The research institutions segment is anticipated to witness the highest CAGR during the forecast period, due to their role in advancing surgical technologies and techniques. These institutions are focused on exploring new applications for automated suturing devices, particularly in complex or specialized surgeries. Additionally, research collaborations with medical device manufacturers help to drive clinical studies, ensuring that automated suturing devices meet evolving surgical needs and contribute to better patient outcomes.
Asia Pacific is expected to have the largest market share during the forecast period due to rapid advancements in healthcare infrastructure, rising surgical volumes, and increasing adoption of minimally invasive surgery (MIS). As countries like China, India, and Japan invest in modernizing their healthcare systems, there is growing demand for advanced surgical technologies. Additionally, the region's large and aging population, along with improving access to medical innovations, fuels the need for precise, efficient surgical tools like automated suturing devices, further driving market growth.
During the forecast period, the North America region is anticipated to register the highest CAGR, driven by advanced healthcare infrastructure, high adoption of minimally invasive surgeries (MIS), and a growing focus on precision surgery. The region's aging population and increasing incidence of surgical procedures further boost demand for efficient and reliable suturing solutions. Additionally, the strong presence of leading medical device manufacturers, ongoing innovations in robotic-assisted surgeries, and higher healthcare spending contribute to the market's growth, positioning North America as a key market for automated suturing devices.
Key players in the market
Some of the key players profiled in the Automated Suturing Devices Market include Medtronic, Stryker Corporation, Smith & Nephew, B. Braun Melsungen AG, Intuitive Surgical, ConMed Corporation, KARL STORZ GmbH & Co. KG, Applied Medical Resources Corporation, Teleflex Incorporated, Toshiba Medical Systems Corporation, Zimmer Biomet, Boston Scientific, Cook Medical, Inovio Pharmaceuticals, 3M, LivaNova PLC, and Hoya Corporation.
In April 2021, Medtronic announced its partnership with Surgical Theater, a startup that markets a Surgery Rehearsal Platform. With the initiative, the companies focused on integrating SynAR's augmented reality of Surgical Theater with Medtronic's StealthStation S8 surgical navigation system.
In September 2020, Smith &Nephew launched Healicoil Knotless Suture Anchor, an addition to its range of modern healing technology for rotator cuff treatment.